JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

The Cervicofacial Flap in Cheek Reconstruction: A Guide for Flap Design.

PURPOSE: The cervicofacial (CF) flap is a random-pattern flap that provides an excellent match for cheek reconstruction. The design of the CF flap varies between different cheek subunits. In this report, the authors review their experience with this flap and present a guide for flap design for different cheek subunits.

MATERIALS AND METHODS: Patients who had cheek reconstruction were screened using the database of the surgical procedures from 2011 to 2016. Seventy-four patients were identified. Data on patient demographics, diagnosis, defect type, and outcome were retrospectively reviewed. Patients who did not have a clear description of the defect or flap design were excluded from the study. The authors divided the cheek into 3 zones and created a guide for flap design for each zone.

RESULTS: Twenty-eight patients with CF flap for cheek reconstruction met the inclusion criteria (21 male [75%] and 7 female [25%]; mean age, 57 yr; range, 8 to 88 yr). Fifty-seven percent had zone A defects, 18% had zone B1 defects, 14% had zone B2 defects, and 11% had multiple-zone defects. Mean follow-up was 4.6 months (0 to 17 months). Ninety-three percent had a successful outcome. Only 2 patients developed wound complications.

CONCLUSION: The CF flap is a versatile flap that provides excellent skin color, thickness, and texture match in cheek reconstruction. Planning the flap design is essential to achieve a good outcome. The present algorithm provides a straightforward method to reliably design the CF flap for cheek reconstruction.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app